dipyridamole has been researched along with Gasser Syndrome in 31 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "From 1976 to 1985, a total of 58 infants and children with the hemolytic-uremic syndrome were randomly assigned to treatment either with heparin and dipyridamole or with supportive management only." | 9.06 | Heparin plus dipyridamole in childhood hemolytic-uremic syndrome: a prospective, randomized study. ( Binda ki Muaka, P; Eeckels, R; Mercieca, V; Proesmans, W; Van Damme, B; Van Damme-Lombaerts, R; Vermylen, J; Vlietinck, R, 1988) |
| "Three children with the hemolytic-uremic syndrome were treated with heparin, aspirin, and dipyridamole." | 7.65 | Preliminary report: treatment of the hemolytic-uremic syndrome with aspirin and dipyridamole. ( Arenson, EB; August, CS, 1975) |
| "From 1976 to 1985, a total of 58 infants and children with the hemolytic-uremic syndrome were randomly assigned to treatment either with heparin and dipyridamole or with supportive management only." | 5.06 | Heparin plus dipyridamole in childhood hemolytic-uremic syndrome: a prospective, randomized study. ( Binda ki Muaka, P; Eeckels, R; Mercieca, V; Proesmans, W; Van Damme, B; Van Damme-Lombaerts, R; Vermylen, J; Vlietinck, R, 1988) |
| "Three children with hemolytic-uremic syndrome (HUS) were successfully treated with plasmapheresis (HUS) were successfully treated with plasmapheresis (PP) combined with early hemodialysis and administration of Aspirin and dipyridamole." | 3.66 | Plasmapheresis as a therapeutic measure in hemolytic-uremic syndrome in children. ( Bulla, M; Bussmann, K; Gillor, A; Gladtke, E; Roth, B; Schrör, K; Tekook, A, 1983) |
| "In four patients with clinical and laboratory manifestations of the hemolytic-uremic syndrome, the administration of aspirin and dipyridamole was associated with a dramatic and rapid increase in the platelet count." | 3.66 | The treatment of the hemolytic-uremic syndrome with inhibitors of platelet function. ( Carone, FA; Green, D; Rossi, EC; Thorsen, CA, 1979) |
| "Three children with the hemolytic-uremic syndrome were treated with heparin, aspirin, and dipyridamole." | 3.65 | Preliminary report: treatment of the hemolytic-uremic syndrome with aspirin and dipyridamole. ( Arenson, EB; August, CS, 1975) |
| "Prednisone alone was judged to be effective in 30 patients with mild TTP-HUS (two relapses and two deaths)." | 2.67 | Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. ( Bell, WR; Braine, HG; Kickler, TS; Ness, PM, 1991) |
| " Optimum drug or combination of drugs and dosage are still controversial." | 1.26 | [Inhibition of platelet function in pediatric medicine (author's transl)]. ( Schmidt, B, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (90.32) | 18.7374 |
| 1990's | 3 (9.68) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gillor, A | 1 |
| Bulla, M | 1 |
| Roth, B | 1 |
| Bussmann, K | 1 |
| Schrör, K | 1 |
| Tekook, A | 1 |
| Gladtke, E | 1 |
| Proesmans, W | 3 |
| Thysell, H | 1 |
| Oxelius, VA | 1 |
| Norlin, M | 1 |
| Willoughby, ML | 1 |
| Fong, JS | 1 |
| de Chadarevian, JP | 1 |
| Kaplan, BS | 1 |
| Schmidt, B | 1 |
| Binda ki Muaka, P | 2 |
| Eeckels, R | 2 |
| Ponticelli, C | 2 |
| Rivolta, E | 1 |
| Imbasciati, E | 2 |
| Rossi, E | 2 |
| Mannucci, PM | 1 |
| Gomperts, ED | 1 |
| Lieberman, E | 1 |
| O'Regan, S | 1 |
| Chesney, RW | 1 |
| Mongeau, JG | 1 |
| Robitaille, P | 1 |
| Oshima, T | 1 |
| Weissbach, G | 1 |
| Zannino, L | 1 |
| Salvadori, G | 1 |
| Thorsen, CA | 1 |
| Rossi, EC | 1 |
| Green, D | 1 |
| Carone, FA | 1 |
| Mori, H | 1 |
| Maestri, O | 1 |
| Brancaccio, D | 1 |
| Berberich, FR | 1 |
| Arenson, EB | 1 |
| August, CS | 1 |
| Naruse, T | 1 |
| Bell, WR | 1 |
| Braine, HG | 1 |
| Ness, PM | 1 |
| Kickler, TS | 1 |
| Valnícek, S | 1 |
| Dolezel, J | 1 |
| Hrubanová, J | 1 |
| Habancová, M | 1 |
| Stejskal, J | 1 |
| Van Damme-Lombaerts, R | 1 |
| Van Damme, B | 1 |
| Mercieca, V | 1 |
| Vlietinck, R | 1 |
| Vermylen, J | 1 |
| Lazebnik, N | 1 |
| Jaffa, AJ | 1 |
| Peyeser, MR | 1 |
| Wu, KK | 1 |
| Ekert, E | 1 |
| George, CR | 1 |
| Slichter, SJ | 2 |
| Quadracci, LJ | 1 |
| Striker, GE | 1 |
| Harker, LA | 2 |
| Utting, JA | 1 |
| Shreeve, DR | 1 |
| Dacie, JV | 1 |
| Powell, HR | 1 |
| Ekert, H | 1 |
| Wehinger, H | 1 |
| Sutor, HA | 1 |
| Schindera, F | 1 |
| Künzer, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Retrospective, Observational Study on the Response to Caplacizumab Treatment in aTTP Patients: the Italian Experience (ROSCAPLI)[NCT05262881] | 50 participants (Anticipated) | Observational | 2022-03-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for dipyridamole and Gasser Syndrome
| Article | Year |
|---|---|
[Congenital and acquired thrombocyte function disorders].
Topics: Aspirin; Blood Platelet Disorders; Dipyridamole; Fibrin Fibrinogen Degradation Products; Heart Defec | 1980 |
Hemolytic-uremic syndrome. Current concepts and management.
Topics: Anemia, Hemolytic; Blood Transfusion; Child; Child, Preschool; Dipyridamole; Epoprostenol; Follow-Up | 1982 |
[Thrombosis prevention and treatment in pediatrics].
Topics: Adolescent; Arterial Occlusive Diseases; Aspirin; Bioprosthesis; Child; Child, Preschool; Coumarins; | 1979 |
[Platelet aggregation inhibitors. Their possible use in pediatric pathology].
Topics: Age Factors; Anti-Inflammatory Agents; Aspirin; Child; Clofibrate; Dextrans; Diabetes Mellitus, Type | 1979 |
Hemolytic-uremic syndrome in pregnancy. Review of the literature and report of a case.
Topics: Adult; Antihypertensive Agents; Dipyridamole; Female; Hemolytic-Uremic Syndrome; Humans; Pregnancy; | 1985 |
2 trials available for dipyridamole and Gasser Syndrome
| Article | Year |
|---|---|
Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients.
Topics: Adolescent; Adult; Aged; Aspirin; Blood Transfusion; Dipyridamole; Female; Hemolytic-Uremic Syndrome | 1991 |
Heparin plus dipyridamole in childhood hemolytic-uremic syndrome: a prospective, randomized study.
Topics: Adolescent; Anuria; Child; Child, Preschool; Dipyridamole; Drug Therapy, Combination; Female; Hemoly | 1988 |
24 other studies available for dipyridamole and Gasser Syndrome
| Article | Year |
|---|---|
Plasmapheresis as a therapeutic measure in hemolytic-uremic syndrome in children.
Topics: Aspirin; Child, Preschool; Dipyridamole; Epoprostenol; Female; Hemolytic-Uremic Syndrome; Humans; In | 1983 |
[Hemolytic-uremic syndrome].
Topics: Biopsy; Child; Dipyridamole; Hemolytic-Uremic Syndrome; Heparin; Humans; Kidney | 1983 |
Successful treatment of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura with fresh frozen plasma and plasma exchange.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aspirin; Child; Child, Preschool; Dipyridamole; Female; | 1982 |
[Inhibition of platelet function in pediatric medicine (author's transl)].
Topics: Age Factors; Aspirin; Child; Dipyridamole; Glomerulonephritis; Graft Rejection; Heart Defects, Conge | 1982 |
The haemolytic uraemic syndrome in childhood: a study of the long-term prognosis.
Topics: Adolescent; Child; Child, Preschool; Dipyridamole; Female; Hemolytic-Uremic Syndrome; Heparin; Human | 1981 |
Hemolytic uremic syndrome in adults.
Topics: Adult; Dipyridamole; Female; Follow-Up Studies; Hemolytic-Uremic Syndrome; Heparin; Humans; Male; Pr | 1980 |
Hemolytic-uremic syndrome.
Topics: Aspirin; Child; Dipyridamole; Hemolytic-Uremic Syndrome; Humans; Peritoneal Dialysis; Plasma Exchang | 1980 |
Aspirin and dipyridamole therapy in the hemolytic-uremic syndrome.
Topics: Aspirin; Child; Child, Preschool; Dipyridamole; Evaluation Studies as Topic; Female; Hemolytic-Uremi | 1980 |
[Predictive factors for development of hemolytic uremic syndrome (HUS) and early intensive treatments for prevention of HUS enterohemorrhagic Escherichia coli infection].
Topics: Abdominal Pain; Adolescent; Age Factors; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroi | 1997 |
The treatment of the hemolytic-uremic syndrome with inhibitors of platelet function.
Topics: Adult; Aspirin; Blood Platelets; Cell Count; Dipyridamole; Female; Hemolytic-Uremic Syndrome; Humans | 1979 |
[An adult case of hemolytic-uremic syndrome treated with inhibitors of platelet functions (author's transl)].
Topics: Aspirin; Blood Platelets; Dipyridamole; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Renal | 1979 |
Late recovery of renal function in a woman with the hemolytic uremic syndrome.
Topics: Adult; Contraceptives, Oral, Combined; Dipyridamole; Ethinyl Estradiol; Female; Hemolytic-Uremic Syn | 1977 |
Letter: Treatment of hemolytic-uremic syndrome.
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Hemolytic-Uremic Syndrome; Heparin; Humans; Strept | 1975 |
Preliminary report: treatment of the hemolytic-uremic syndrome with aspirin and dipyridamole.
Topics: Acute Disease; Anemia, Hemolytic; Aspirin; Blood Platelet Disorders; Blood Platelets; Blood Transfus | 1975 |
[Kidney diseases associated with hemolytic uremic syndrome,thrombotic thrombocytopenic purpura and disseminated intravascular coagulation].
Topics: Adolescent; Adult; Aspirin; Dipyridamole; Disseminated Intravascular Coagulation; Female; Hemolytic- | 1992 |
Importance of blood clotting tests in the diagnosis of haemolytic-uremic syndrome and experience with its treatment.
Topics: Blood Coagulation Tests; Child, Preschool; Dipyridamole; Fibrin Fibrinogen Degradation Products; Hem | 1988 |
Microvascular thrombosis: pathophysiology and new strategies.
Topics: Arachidonic Acid; Arachidonic Acids; Dipyridamole; Disseminated Intravascular Coagulation; Epoproste | 1985 |
Letter: Thrombolytic therapy in haemolytic-uraemic syndrome.
Topics: Child; Dipyridamole; Hemolytic-Uremic Syndrome; Heparin; Humans; Shwartzman Phenomenon; Streptokinas | 1974 |
A kinetic evaluation of hemostasis in renal disease.
Topics: Aspirin; Blood Coagulation; Complement System Proteins; Diabetic Nephropathies; Dipyridamole; Fibrin | 1974 |
Platelet and fibrinogen consumption in man.
Topics: Blood Cell Count; Blood Platelets; Catheterization; Cell Survival; Dipyridamole; Disseminated Intrav | 1972 |
Haemolytic-uraemic syndrome in an adult with pericarditis and pleurisy.
Topics: Adult; Alopecia; Anemia, Hemolytic; Aspirin; Dipyridamole; Female; Hemolytic-Uremic Syndrome; Hepari | 1973 |
[Hemolytic-uremic syndrome and microangiopathic hemolytic anemia].
Topics: Adrenal Cortex Hormones; Anemia, Hemolytic; Aspirin; Dextrans; Dipyridamole; Drug Hypersensitivity; | 1973 |
Streptokinase and anti-thrombotic therapy in the hemolytic-uremic syndrome.
Topics: Aspirin; Biopsy; Child; Child, Preschool; Dipyridamole; Hemolytic-Uremic Syndrome; Hemorrhage; Hepar | 1974 |
[Therapy of the hemolytic-uremic syndrome].
Topics: Aspirin; Dipyridamole; Hemolytic-Uremic Syndrome; Heparin; Humans; Methods; Peritoneal Dialysis; Pla | 1974 |